Table 1. ANOVAs applied to oxyhemoglobin data.

PFC subregions	Effect	DF	F	Pr > F	Partial Eta Squared
A. ANOVA applied to ΔO2HbAVG for Periods, 1st trial
DLPFCL	Period (3)	2, 9	26.127	.000*	0.659
DLPFCR	Period (3)	2, 9	26.567	.000*	0.663
VLPFCL	Period (3)	2, 9	24.848	.000*	0.648
VLPFCR	Period (3)	2, 9	27.090	.000*	0.667
FPFCL	Period (3)	2, 9	43.073	.000*	0.761
FPFCR	Period (3)	2, 9	48.141	.000*	0.781
OFCL	Period (3)	2, 9	.720	.496	0.051
OFCR	Period (3)	2, 9	.346	.710	0.025
B. ANOVA applied to ΔO2HbAVG for recovery period, all trials
DLPFCL	Trial (6)	2, 59	4.145	.003*	0.277
DLPFCR	Trial (6)	2, 59	3.326	.011*	0.235
VLPFCL	Trial (6)	2, 59	4.207	.003*	0.280
VLPFCR	Trial (6)	2, 59	3.891	.004*	0.265
FPFCL	Trial (6)	2, 59	3.956	.004*	0.268
FPFCR	Trial (6)	2, 59	4.593	.001*	0.298
OFCL	Trial (6)	2, 59	10.634	.000*	0.496
OFCR	Trial (6)	2, 59	7.524	.000*	0.411

PFC subregion sides are identified by _L = left, _R = right. α = 0.05,

* = significance.